Clara Health
Partner

Do you suffer from migraines?

Learn about a new, no cost research study.


Right now, doctors at select centers in the U.S. are accepting participants for a new clinical research study.

This study is for a new investigational oral drug for migraines that aims to reduce the pain from migraines. In past studies, more than 3 times the number of patients who responded to treatment preferred rimegepant over their previous therapy.

About Migraine

Clinicians use a number of pharmacologic agents for the acute treatment of migraine, but there remains a significant unmet medical need for a novel migraine-specific medication that does not increase the risk of cardiovascular liability.

Qualified participants may receive:

  • $475 compensation for time and travel
  • Study related medications and examinations at no cost

Is this study right for me?

Who is this study for?

Coastal Carolina Research Center is looking for qualified volunteers who:

  • Are at least 18 years of age or older
  • Have had at least 1 year history of migraines

 

What should I expect?

Rimegepant is an oral medication.

 

Frequently asked questions

What are the past study results for rimegepant?

In each trial, a single dose of rimegepant, without any rescue medications, was superior to placebo for pain freedom and pain relief. The efficacy and safety profile of rimegepant has now been observed across three randomized controlled trials, including a Phase 2b study.

""I became a participant in a Hypertension study at Coastal Carolina Research Center almost a year ago. Having worked in the medical field for over 40 years, I was very impressed with the care and professionalism of the nursing and medical staff. They make patients feel very special and their concern and care is very evident.""

- A.B., Charleston, SCA.B., Charleston, SC

Interested in learning more?

Fill out the form, call us at 843-856-3784 and Press # 1, or email Samantha at swilley@coastalcarolinaresearch.com